ResearchWho?
    • Profile Image
    박래길
    Position 교수
    Current Department 광주과학기술원 의생명공학과
    프로필
    연구 성과
    논문[42]
    #42. Intracellular cholesterol transport inhibition Impairs autophagy flux by decreasing autophagosome-lysosome fusion
    Journal Information 2022.11.25 · CELL COMMUNICATION AND SIGNALING · 20(1):189
    Identifier (DOI) https://doi.org/10.1186/s12964-022-00942-z
    #41. Combined Therapy of Low-Dose Angiotensin Receptor–Neprilysin Inhibitor and Sodium–Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects
    Journal Information 2022.11 · Pharmaceutics · 14(12):2629
    Identifier (DOI) https://doi.org/10.3390/pharmaceutics14122629
    프로시딩[1]
    #1. Arctigenin Inhibits Adipogenesis by Inducing AMPK Activation and Reduces Weight Gain in High-Fat Diet-Induced Obese Mice.
    Journal Information 2016.04
    Identifier (DOI) https://doi.org/10.1002/jcb.25509
    발표[73]
    #73. Arctigenin Inhibits Adipogenesis by Inducing AMPK Activation and Reduces Weight Gain in High-Fat Diet-Induced Obese Mice.
    Date 2016.4
    #72. Efforts to Lead Peroxisome Research in Korea
    Organization 한국분자.세포생물학회 페록시좀 분과
    Date 2015.9
    특허[2]
    #2. 신규 급성백혈병의 진단용 마커
    Identifier [출원] 2014-0195946
    Patent Country 대한민국
    #1. 나프토퀴논계 화합물을 포함하는 난청의 치료 또는 예방을 위한 조성물
    Identifier [출원] 24547005
    Patent Country 일본
    팔로우 추천